IDH1 and acute myeloid leukemia: Likewise, the frequently occurring IDH1 R132H mutation in CPT1Alow AML patients is located in the catalytic site of the IDH1 protein which converts α-ketoglutarate to 2-hydroxyglutarate oncometabolite [1, 8, 60].